| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/21/1994 | CA2153661A1 Methods and compositions for the direct concentrated delivery of passive immunity |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153568A1 Methods of delivering agents to target cells |
| 07/21/1994 | CA2153486A1 Ras associated gap proteins |
| 07/21/1994 | CA2153409A1 Leukocyte derived growth factors |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153228A1 Peptide inhibitors of cell adhesion |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/21/1994 | CA2153051A1 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | CA2153046A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | CA2152818A1 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | CA2152509A1 Method to predict active growth of bacteria adhered to a surface |
| 07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
| 07/21/1994 | CA2152380A1 New peptides |
| 07/21/1994 | CA2152379A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | CA2152281A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | CA2152185A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | CA2152184A1 Thiazolidine derivatives; process for preparing the same and drugs containing them |
| 07/21/1994 | CA2152183A1 Pyrrolidine and thiazolidine derivatives; process for preparing the same and drugs containing them |
| 07/21/1994 | CA2151486A1 Tgf-beta formulation for inducing bone growth |
| 07/21/1994 | CA2150574A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | CA2149444A1 Anticaries compositions |
| 07/21/1994 | CA2131623A1 Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | CA2131165A1 Anti-cancer utility of hcg vaccines |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0606881A1 Cyclic pentapeptides having a beta-turn and a gamma-turn |
| 07/20/1994 | EP0606869A1 Promotor sequence of the p55 tumor necrosis factor receptor |
| 07/20/1994 | EP0606816A1 Procedure for preparing salmon calcitonin |
| 07/20/1994 | EP0606804A2 Marker for neurotensin receptor |
| 07/20/1994 | EP0606753A2 Non-reducing saccharide-forming enzyme, and its preparation and uses |
| 07/20/1994 | EP0606518A1 Intercellular adhesion molecules and their binding ligands |
| 07/20/1994 | EP0606464A1 Peptides capable of controlling acrosome reaction |
| 07/20/1994 | EP0606463A1 Neuromedin b receptor antagonists |
| 07/20/1994 | EP0606391A1 Inhibition of vascular narrowing using anti-padgem antibodies |
| 07/20/1994 | EP0606222A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
| 07/20/1994 | EP0470989B1 Use of anti-B2 microglobulin monoclonal antibodies |
| 07/20/1994 | EP0378641B1 Novel antimicrobial peptide, compositions containing same and uses thereof |
| 07/20/1994 | EP0366777B1 Stimulation of chemotaxis by chemotactic peptides |
| 07/20/1994 | EP0362283B1 Bovine interleukin-1 alpha |
| 07/20/1994 | EP0209568B1 Dna sequences, recombinant dna molecules and processes for producing human lipocortin-like polypeptides |
| 07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
| 07/20/1994 | CN1089606A Antiretroviral acyl compounds |
| 07/20/1994 | CN1089505A Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 07/20/1994 | CA2113695A1 Fibrinogen processing apparatus, method and container |
| 07/19/1994 | US5331094 Purified active somatostatin receptor |
| 07/19/1994 | US5331090 CR2 ligand compositions and methods for modulating immune cell functions |
| 07/19/1994 | US5331089 Peptides useful as tachykinin agonists |
| 07/19/1994 | US5331008 Thioester enantiomeric compounds and their therapeutic uses |
| 07/19/1994 | US5330978 Cardiovascular disorders, hypotensive agents, vasodilation |
| 07/19/1994 | US5330975 Bacterial toxin neutralizer |
| 07/19/1994 | US5330974 Therapeutic fibrinogen compositions |
| 07/19/1994 | US5330973 Lipopeptide derivatives |
| 07/19/1994 | US5330972 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus |
| 07/19/1994 | US5330971 Insulin-like growth factor I, genetic engineering |
| 07/19/1994 | US5330907 Method of preparing activated protein C |
| 07/19/1994 | US5330897 Sialic acid binding lectin of protozoan origin |
| 07/19/1994 | US5330896 Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells |
| 07/19/1994 | US5330895 Detection reagent and antibody specific for dopamine releasing protein |
| 07/19/1994 | CA1330791C Oral delivery system |
| 07/19/1994 | CA1330769C Process for selectively extracting the lactoserum metalloproteins by adsorption and elution |
| 07/19/1994 | CA1330768C Monoclonal anti-human granulocyte colony stimulating factor antibody |
| 07/19/1994 | CA1330758C Method of treating mastitis and other staphylococcal infections |
| 07/19/1994 | CA1330757C Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 07/15/1994 | CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 07/14/1994 | DE4300222A1 Calf thymus cell nuclei phospho peptide of approximately 9950 daltons |
| 07/14/1994 | CA2113313A1 Pentapeptide with specific conformaton, its production and use |
| 07/13/1994 | EP0606003A1 Method for minimizing and containing ischemic and reperfusion injury |
| 07/13/1994 | EP0605983A2 Insulin analogs |
| 07/13/1994 | EP0605963A2 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 07/13/1994 | EP0605913A1 Use of bile salt-activated lipase as dietary supplement |
| 07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |
| 07/13/1994 | EP0605653A1 A new form of liposaccharide binding protein (lbp) |
| 07/13/1994 | EP0605589A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
| 07/13/1994 | EP0605561A1 Annexin xi |
| 07/13/1994 | EP0605522A1 Production of chimeric antibodies - a combinatorial approach |
| 07/13/1994 | EP0605501A1 Method and compositions for the treatment of cerebral palsy |
| 07/13/1994 | EP0605484A1 Peptides having growth hormone releasing activity |
| 07/13/1994 | EP0605466A1 Method and compositions for cellular reprogramming |
| 07/13/1994 | EP0605462A1 New isosteric peptides |
| 07/13/1994 | EP0605442A1 Recombinant antibodies for human therapy |
| 07/13/1994 | EP0605428A1 Hormone-secreting cells maintained in long-term culture |
| 07/13/1994 | EP0579742A4 Product and method for improving keratinocyte adhesion to the dermis |
| 07/13/1994 | EP0559751A4 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 07/13/1994 | EP0387352B1 Enteric formulations of physiologically active peptides and proteins |
| 07/13/1994 | EP0341290B1 Immunoglobulin e competitor |
| 07/13/1994 | EP0327640B1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome |
| 07/12/1994 | US5328997 Processes for making proteins having anticoagulant properties |
| 07/12/1994 | US5328991 Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
| 07/12/1994 | US5328988 Interleukin-7 |
| 07/12/1994 | US5328987 Dna sequences for mucosal immune response |
| 07/12/1994 | US5328986 Smooth muscle mitogen |
| 07/12/1994 | US5328985 Recombinant streptavidin-protein chimeras useful for conjugation of molecules in the immune system |
| 07/12/1994 | US5328955 Using a hydrophilic polyethylene |
| 07/12/1994 | US5328916 Heterocyclic compounds useful for inhibition of renin |
| 07/12/1994 | US5328909 Cyclopropenone derivatives |
| 07/12/1994 | US5328900 Anti-thrombotic peptide and pseudopeptide derivatives |